Single Use Support continues to grow
Single Use Support Headquarters Kufstein, Austria
Single Use Support. Pioneering Biopharma. Fluid and Cold Chain Management Process Solution Provider Innovative process solution provider Single Use
Support continues to deliver strong organic growth, supported by an expansion in its employee base. With a successful year 2023 in the rear-view mirror, 2024 is already shaping up to be even better.
KUFSTEIN, Austria, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Single Use Support has established the groundwork for an exciting new year ahead: the process solution provider anticipates further growth across its global operations.
More than 70% growth of non-COVID business
Following strong growth of COVID-related projects in previous years, Single Use Support grew its non-COVID business by more than 70% in 2023. The Austrian-based process solution provider serves the most innovative and prominent pharmaceutical companies to develop novel therapies and advanced lifesaving therapeutics. The fluid management specialist covers well-established drug classes such as monoclonal antibodies as well as emerging therapeutics in areas such as cell and gene therapies, antibody-drug conjugates, and others.
Employee base grows by 40%
The continued growth of the business is secured by a significant increase in personnel. Single Use Support grew its workforce to over 170 employees, an increase of more than 40% over the last six months. Christian Praxmarer, CEO of Single Use Support, is fully committed to continuing the company’s success story: “Together with our team and with our customers we will continue to grow by offering innovative solutions that address the daily challenges faced by manufacturers in the biopharma industry.”
Strong order backlog for 2024
Single Use Support’s award-winning solutions continued to gain significant traction among major pharmaceutical companies and C(D)MOs globally. Several well-known industry participants have already placed significant orders for consumables and platform systems designed to aliquot, freeze/thaw, store, and ship high-value drug substances. “Based on our current order backlog and ongoing project tenders, we feel confident that we can deliver strong non-COVID-related year-over-year growth in 2024,” added Christopher Dürolf, CFO of Single Use Support.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0b81e312-6fb3-404c-a50b-03878e6d26fc
Michael Eder
m.eder@susupport.com
- 《以你为名的夏天》杀青 翟潇闻吴施乐携手演绎夏日清甜爱恋
- 刘洋洋|2024总台端午特别节目|《端午吟》戏腔惊艳声动心弦
- Acronis launches new Cyber Cloud data center in Berlin
- Mumena Mushinge Appointed to Baushi Royal Foundation, Signaling a New Era of Leadership and Wealth C
- 端午节遇上火星人集成灶 让我们一起感受文化,追求品质
- Black Hat Asia 2024:新加坡活动的完整日程安排
- 多项财务指标创历史新高,海天味业冲刺港股「中国调味品第一股」
- PingPong打通跨境支付“最后一公里”,游向新蓝海
- 2023年度慈善盛典举办,华人慈善家卓顺发这一发言获得满座掌声
- 消散暑气重新找回好胃口 麻辣or清爽美食全都要
- 李春波新歌《小玲》上线 张建全书写乡村少年的懵懂爱情
- 沉痛悼念三和骄子2000级学生郭建峰
- Galderma Delivers Record Net Sales of 2.2 Billion USD and 10.8% Year-on-Year Growth at Constant Curr
- 2025DAC设计师品牌IP增长峰会圆满落幕
- Yachting: maxi monohull Black Jack 100, member of Yacht Club de Monaco, triumphs at the Fastnet
- 第45届澳大利亚旅游交易会在布里斯班盛大召开 澳大利亚旅游市场步入增长新阶段
- 坚持“真功效”理念 HBN依托科研创新引领中国护肤市场迈向新高度
- 技术标杆再升级:人民出行获南宁市工程研究中心认证,引领共享出行革新
- 中国首家BOSS旗舰店于上海静安嘉里中心盛大启幕 汪顺惊喜亮相新店开幕酒会
- 法国娇兰×原神破次元联动 共探奇迹绽放 梦幻之旅,跨界奇遇
推荐
-
国足13次出战亚洲杯首次小组赛0进球 北京时间1月23日消息,2023亚洲杯小组 资讯
-
奥运冠军刘翔更新社交账号晒出近照 时隔473天更新动态! 2月20日凌晨2点,奥运冠军刘翔更新社交账号晒 资讯
-
看新东方创始人俞敏洪如何回应董宇辉新号分流的? (来源:中国证券报) 东方甄选净利润大幅下滑 资讯
-
新增供热能力3200万平方米 新疆最大热电联产项目开工 昨天(26日),新疆最大的热电联产项目—&md 资讯
-
透过数据看城乡居民医保“含金量” 缴费标准是否合理? 记者从国家医保局了解到,近期,全国大部分地区 资讯
-
周星驰新片《少林女足》在台湾省举办海选,吸引了不少素人和足球爱好者前来参加 周星驰新片《少林女足》在台湾省举办海选,吸 资讯
-
中央气象台连发四则气象灾害预警 暴雪橙色预警+冰冻橙色预警+大雾黄色预警+ 资讯
-
一个“江浙沪人家的孩子已经不卷学习了”的新闻引发议论纷纷 星标★ 来源:桌子的生活观(ID:zzdshg) 没 资讯
-
王自如被强制执行3383万 据中国执行信息公开网消息,近期,王自如新增一 资讯
-
海南大学生返校机票贵 有什么好的解决办法吗? 近日,有网友在“人民网领导留言板&rdqu 资讯